Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation SLC17A6_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-33911 | SLC17A6 | down-regulates | hsa-mir-17-3p | represses | R-371 | 52 | 4 | Drugs (31) Regulator Drugs (0)Regulon Drugs (31)RILAPLADIB, CALCIFEDIOL, BECOCALCIDIOL, TACROLIMUS, INTERFERON GAMMA-1B, TEMSIROLIMUS, PARICALCITOL, INECALCITOL, BATOCLIMAB, ERGOCALCIFEROL, CHOLECALCIFEROL, NIPOCALIMAB, DOXERCALCIFEROL, CALCITRIOL, BRENSOCATIB, EVEROLIMUS, DARAPLADIB, ELDECALCITOL, CALCIPOTRIENE, EMRICASAN, SIROLIMUS, EFGARTIGIMOD ALFA, SEOCALCITOL, ROZANOLIXIZUMAB, VERNAKALANT, PEFCALCITOL, VERNAKALANT HYDROCHLORIDE, LUNACALCIPOL, PIMECROLIMUS, DP001, ALFACALCIDOL |
CMF-33912 | SLC17A6 | down-regulates | hsa-mir-17-3p | represses | R-2500 | 52 | 4 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-33913 | SLC17A6 | down-regulates | hsa-mir-17-3p | represses | R-2585 | 52 | 4 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-33914 | SLC17A6 | down-regulates | hsa-mir-17-3p | represses | R-1679 | 52 | 4 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |